Neuropathy Therapy Ctr-Grand is categorized under Rehabilitation Center, Outpatient Treatment in Grand Rapids, MI and active since 2012.
Neuropathy Therapy Ctr-Grand was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 358 68th St Sw, Grand Rapids, Michigan MI 49548 or by phoning (616) 773-7246. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Neuropathy Therapy Ctr-Grand |
Address: | 358 68th St Sw, Grand Rapids, Michigan 49548 |
Phone Number: | (616) 773-7246 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 6211110 |
Share This Business: |
Neuropathy Therapy Ctr-Grand was started in 2012 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact for inquiries that concern Neuropathy Therapy Ctr-Grand by calling the company number (616) 773-7246, as your correspondence is most welcome. Additionally, the physical location of the single location of Neuropathy Therapy Ctr-Grand can be found at the coordinates 42.84081,-85.67276 as well as the street address 358 68th St Sw in Grand Rapids, Michigan 49548.
For its online presence, you may visit Neuropathy Therapy Ctr-Grand’s website at and engage with its social media outlets through on Twitter and on Facebook.